Tandem Diabetes Care announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. Tandem Source is now available for all Tandem pump users and their HCPs in the United States, with international availability expected in 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TNDM:
- Citi entering 2024 ‘cautiously optimistic’ on U.S. MedTech companies
- Tandem Diabetes launches updated t:slim X2 insulin pump software with DexCom CGM
- Tandem Diabetes price target lowered to $39 from $62 at Barclays
- Tandem Diabetes price target lowered to $35 from $50 at Craig-Hallum
- Tandem Diabetes price target lowered to $22 from $34 at TD Cowen